Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Novartis Pulls Plug on Aliskiren Study - MedPage Today |
 |
 |
|
MedPage Today In this case, the patients had type 2 diabetes and renal impairment. The Data Monitoring Committee noted an increased incidence after 18 to 24 months of non-fatal stroke, renal complications, hyperkalemia, and hypotension in those taking the drug. ... Novartis announces termination of ALTITUDE study with Rasilez®/ Tekturna® in |
